Free Trial

Charles Schwab Investment Management Inc. Has $74.70 Million Stock Position in Maximus, Inc. (NYSE:MMS)

Maximus logo with Business Services background
Remove Ads

Charles Schwab Investment Management Inc. lifted its stake in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 7.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,000,664 shares of the health services provider's stock after purchasing an additional 71,598 shares during the period. Charles Schwab Investment Management Inc. owned approximately 1.75% of Maximus worth $74,700,000 at the end of the most recent reporting period.

Several other hedge funds have also modified their holdings of MMS. Nordea Investment Management AB bought a new position in Maximus in the 4th quarter valued at $4,618,000. Fort Washington Investment Advisors Inc. OH boosted its holdings in Maximus by 39.1% in the fourth quarter. Fort Washington Investment Advisors Inc. OH now owns 296,476 shares of the health services provider's stock valued at $22,132,000 after acquiring an additional 83,390 shares during the last quarter. IFP Advisors Inc increased its position in Maximus by 62.4% in the fourth quarter. IFP Advisors Inc now owns 786 shares of the health services provider's stock worth $59,000 after purchasing an additional 302 shares during the period. Mirae Asset Global Investments Co. Ltd. bought a new stake in Maximus during the 4th quarter worth about $1,113,000. Finally, Versor Investments LP raised its holdings in Maximus by 213.5% during the 3rd quarter. Versor Investments LP now owns 8,500 shares of the health services provider's stock worth $792,000 after purchasing an additional 5,789 shares during the last quarter. 97.21% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several brokerages have recently commented on MMS. Raymond James upgraded shares of Maximus from a "market perform" rating to an "outperform" rating and set a $90.00 price target for the company in a research report on Thursday, January 2nd. StockNews.com lowered shares of Maximus from a "buy" rating to a "hold" rating in a report on Friday, February 14th.

Remove Ads

Check Out Our Latest Stock Analysis on Maximus

Maximus Trading Up 0.3 %

NYSE:MMS traded up $0.22 during mid-day trading on Friday, hitting $67.06. The company had a trading volume of 457,007 shares, compared to its average volume of 481,753. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.72 and a current ratio of 1.72. Maximus, Inc. has a fifty-two week low of $63.77 and a fifty-two week high of $93.97. The firm has a market cap of $3.80 billion, a P/E ratio of 14.42 and a beta of 0.71. The business's fifty day moving average is $72.22 and its two-hundred day moving average is $79.65.

Maximus (NYSE:MMS - Get Free Report) last released its quarterly earnings data on Thursday, February 6th. The health services provider reported $1.61 earnings per share for the quarter, topping the consensus estimate of $1.39 by $0.22. Maximus had a net margin of 5.28% and a return on equity of 21.95%. As a group, research analysts expect that Maximus, Inc. will post 6.15 earnings per share for the current year.

Maximus Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, February 28th. Shareholders of record on Saturday, February 15th were paid a $0.30 dividend. The ex-dividend date of this dividend was Friday, February 14th. This represents a $1.20 dividend on an annualized basis and a yield of 1.79%. Maximus's payout ratio is 25.81%.

Insiders Place Their Bets

In other Maximus news, insider Ilene R. Baylinson sold 14,500 shares of the stock in a transaction dated Wednesday, February 19th. The stock was sold at an average price of $68.14, for a total transaction of $988,030.00. Following the completion of the transaction, the insider now owns 2,512 shares in the company, valued at approximately $171,167.68. This represents a 85.23 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Bruce Caswell acquired 3,500 shares of Maximus stock in a transaction dated Tuesday, December 17th. The shares were purchased at an average cost of $70.64 per share, with a total value of $247,240.00. Following the completion of the transaction, the chief executive officer now directly owns 275,929 shares of the company's stock, valued at $19,491,624.56. This trade represents a 1.28 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Corporate insiders own 1.60% of the company's stock.

Maximus Company Profile

(Free Report)

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

Featured Articles

Institutional Ownership by Quarter for Maximus (NYSE:MMS)

Should You Invest $1,000 in Maximus Right Now?

Before you consider Maximus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.

While Maximus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for March 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Institutions Are Dumping These 3 Stocks—Should You?
Will Tesla’s Robot Future Save Its Falling Stock?
NVIDIA’s Dip Is a Gift—Here’s Why It Won’t Last

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads